Clinical trials are essential for advancing new therapies, yet traditional models remain slowed by high operational costs, long timelines, and limited patient access—challenges compounded by the fact that over 80% of trials occur in a small cluster of countries. Digital technologies now enable decentralized and hybrid approaches that expand geographic reach, improve participant diversity, and enhance trial efficiency through tools such as remote monitoring, telehealth, and mobile engagement.

HITLAB reviewed the features, capabilities, and value proposition of the Jeeva Clinical Trials platform by synthesizing secondary information from white papers, case studies, product documentation, blogs, and publicly available materials. A descriptive, secondary-data review was used to present a clear and concise overview of how Jeeva’s digital solutions address key challenges and support diverse clinical research needs across multiple therapeutic areas